VEGFA and age-related macular degeneration: There were no significant differences in sex, type of anti-VEGF agents, AMD subtype, proportion of patients taking anticoagulants, baseline BCVA, mean central foveal thickness (CFT), mean thickness of the SMHs, and mean thickness of the hemorrhagic pigment epithelial detachment (PED)s between the two groups (P > 0.05 for all comparisons).